Sino Medical Sciences Technology Inc. (688108.SS)
CNY 10.24
(-0.49%)
CNY 10.24
(-0.49%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 343.25 Million CNY | 77.99% |
| 2022 | 192.85 Million CNY | -0.77% |
| 2021 | 194.35 Million CNY | -40.64% |
| 2020 | 327.41 Million CNY | -24.89% |
| 2019 | 435.91 Million CNY | 14.59% |
| 2018 | 380.42 Million CNY | 18.14% |
| 2017 | 322 Million CNY | 21.23% |
| 2016 | 265.61 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 104.79 Million CNY | -13.93% |
| 2024 Q1 | 90.4 Million CNY | -8.34% |
| 2024 Q2 | 121.75 Million CNY | 34.67% |
| 2023 Q4 | 98.64 Million CNY | 18.37% |
| 2023 Q2 | 88.11 Million CNY | 20.43% |
| 2023 FY | 343.25 Million CNY | 77.99% |
| 2023 Q3 | 83.33 Million CNY | -5.43% |
| 2023 Q1 | 73.16 Million CNY | 171.73% |
| 2022 Q3 | 55.62 Million CNY | 8.62% |
| 2022 FY | 192.85 Million CNY | -0.77% |
| 2022 Q4 | 26.92 Million CNY | -51.59% |
| 2022 Q2 | 51.21 Million CNY | -13.34% |
| 2022 Q1 | 59.09 Million CNY | -19.3% |
| 2021 Q3 | 42.49 Million CNY | -16.55% |
| 2021 Q2 | 50.92 Million CNY | 83.79% |
| 2021 Q4 | 73.22 Million CNY | 72.29% |
| 2021 FY | 194.35 Million CNY | -40.64% |
| 2021 Q1 | 27.7 Million CNY | -47.02% |
| 2020 FY | 327.41 Million CNY | -24.89% |
| 2020 Q4 | 52.3 Million CNY | -46.99% |
| 2020 Q3 | 98.67 Million CNY | -5.42% |
| 2020 Q2 | 104.32 Million CNY | 44.65% |
| 2020 Q1 | 72.12 Million CNY | -42.66% |
| 2019 FY | 435.91 Million CNY | 14.59% |
| 2019 Q2 | 107.48 Million CNY | 6.05% |
| 2019 Q1 | 101.35 Million CNY | -6.76% |
| 2019 Q4 | 125.78 Million CNY | 24.2% |
| 2019 Q3 | 101.27 Million CNY | -5.78% |
| 2018 Q4 | 108.7 Million CNY | 0.0% |
| 2018 Q1 | 92.75 Million CNY | 0.0% |
| 2018 FY | 380.42 Million CNY | 18.14% |
| 2017 FY | 322 Million CNY | 21.23% |
| 2016 FY | 265.61 Million CNY | 0.0% |